Abstract 6‐Aminopyrazin‐2(1 H )‐one, when incorporated as a pyrimidine‐base analog into an oligonucleotide chain, presents a H‐bond acceptor‐donor‐donor pattern to a complementary purine analog. When paired with the corresponding donor‐acceptor‐acceptor purine in oligonucleotides, the heterocycle selectively contributes to the stability of the duplex, presumably by forming a base pair of Watson‐Crick geometry joined by a non‐standard H‐bonding pattern. Aspects of the nucleoside chemistry, including syntheses of the β‐furanosyl ribonucleoside 1 , the ribonucleoside triphosphate 2 and the ribonucleoside bisphosphate 3 of 6‐aminopyrazin‐2(1 H )‐one are reported here. In aqueous solution, the ribonucleoside 1 was found to undergo acid‐ and base‐catalyzed rearrangement with an apparent half‐life of ca. 63 h at neutral pH and 30°. The rearrangement appears to be specific acid‐ and base‐catalyzed. The thermodynamically most stable compound formed during this rearrangement reaction was isolated by HPLC and shown to be the β‐pyranosyl form 4 of the 6‐aminopyrazin‐2(1 H )‐one nucleoside in its 4 C 1 chair conformation. This reactivity of 1 under physiological conditions may explain why Nature does not use this particular heterocyclic system to implement an acceptor‐donor‐donor H‐bonding pattern in the genetic alphabet.
No takes yet. Share an insight, caveat, or question.
Voegel et al. (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: